COSMOS Pharmaceutical (TSE:3349) COGS-to-Revenue : 0.80 (As of Feb. 2024)

View and export this data going back to 2004. Start your Free Trial

What is COSMOS Pharmaceutical COGS-to-Revenue?

COSMOS Pharmaceutical's Cost of Goods Sold for the three months ended in Feb. 2024 was 円192,148 Mil. Its Revenue for the three months ended in Feb. 2024 was 円238,881 Mil.

COSMOS Pharmaceutical's COGS to Revenue for the three months ended in Feb. 2024 was 0.80.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. COSMOS Pharmaceutical's Gross Margin % for the three months ended in Feb. 2024 was 19.56%.

COSMOS Pharmaceutical COGS-to-Revenue Historical Data

The historical data trend for COSMOS Pharmaceutical's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

COSMOS Pharmaceutical COGS-to-Revenue Chart

COSMOS Pharmaceutical Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

COGS-to-Revenue

Get a 7-Day Free Trial

0.80

COSMOS Pharmaceutical Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
COGS-to-Revenue	Get a 7-Day Free Trial															0.80	0.80	0.81	0.80	0.80

COSMOS Pharmaceutical COGS-to-Revenue Calculation

COSMOS Pharmaceutical's COGS to Revenue for the fiscal year that ended in May. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	658979	/	827697
	=	0.80

COSMOS Pharmaceutical's COGS to Revenue for the quarter that ended in Feb. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	192148	/	238881
	=	0.80

COSMOS Pharmaceutical (TSE:3349) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

COSMOS Pharmaceutical's Gross Margin % for the three months ended in Feb. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	192148 / 238881
	=	19.56 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

COSMOS Pharmaceutical COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of COSMOS Pharmaceutical's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

COSMOS Pharmaceutical (TSE:3349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » COSMOS Pharmaceutical Corp (TSE:3349) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, JPN, 812-0013

Website

http://www.cosmospc.co.jp

COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.

COSMOS Pharmaceutical (TSE:3349) Headlines

No Headlines